Researchers may use this solution in laboratory settings requiring accurate small-volume preparation and regulated sterile handling conditions
The diluent for any investigational peptide must always be the one specified in the trial protocol or product dossier
Each single-dose pen or single-dose vial contains a 0.5 mL solution of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg of tirzepatide and the following excipients: sodium chloride (4.1 mg), sodium phosphate dibasic heptahydrate (0.7 mg), and water for injection
Verify the pharmacy's credentials, including state licensure and, if applicable, accreditation by organizations such as the Pharmacy Compounding Accreditation Board (PCAB)
Insurers classify them as elective or experimental, and coverage is not available regardless of the clinical rationale
Semaglutide Patient Safety Information What happens if I stop the medication